Sava’s Post

We are very excited to share that Sava is emerging from stealth to announce that we have raised an $8 million round led by Balderton Capital and Exor Ventures! 🎉 At SAVA, we are pioneering a new standard in health monitoring. We have developed the first continuous biosensing platform offering low-cost, pain-free, and multi-biomarker sensing capabilities, powering use cases that were previously impossible outside of a lab. Traditional healthcare operates too reactively: a system marked by inefficiency, high costs and centralization. Enabling real-time access to deep health information, the very molecules flowing under our skin, will unlock a new era of preventative care. One where we can make health decisions with unprecedented knowledge of our bodies, spot issues before it's too late, and tailor our daily lives according to what uniquely works for us. We are thrilled to have the support of our investors as we work towards our goal of defining a new paradigm in health monitoring – preventative, personalized, and effortless. A special thanks to all our investors who have worked with us since day one, Sweet Capital, JamJar Investments, Exceptional Ventures, SOSV, and all our angel investors. We could not have made it this far without your support and are thrilled to continue this exciting journey with you to transform healthcare. Finally, a huge shoutout to our incredible team for their hard work. The work you do every single day, is truly breathtaking and incredibly inspiring! Thank you to Kai Nicol-Schwarz at Sifted for a great article and stay tuned for more updates as we continue to grow! 🚀 Find Sifted article here → https://lnkd.in/dgrCJUEx Read our full press release → https://lnkd.in/de4hK8pQ Check out our new website! → https://www.sava.health/ #health #healthtech #biotech #startup #diabetes #funding #CGM #investment #diabetestech #wearables #biosensor

Thanks Exceptional Ventures! It has been great working with you since the very beginning as one of our early supporters. Special thanks to Paolo Pio for all your help! Read the article here → https://lnkd.in/ecqcMfzX

Last week, Sava attended #ADA2024 in Orlando for the first time. It was great to connect with healthcare professionals, researchers, and innovators in the diabetes community. 💡 Here are our key takeaways: ⚡ Excitement about multi-analyte - Although glucose monitoring changed the diabetes space, there is increasing excitement about what multi-analyte could do for both diabetes and other health conditions. 📈 CGMs expanding to broader populations - The research presented at ADA showed a clear trend towards expanding CGM technology to more people, including those with Type 2, gestational diabetes, and pre-diabetes. To enable greater access, we need a low-cost, user-friendly, seamless solution. 🥊 The duopoly is strong, but appetite for innovation is growing - All the discussions we had reached the same conclusion: we desperately need more innovation and disruption in the diabetes space. While the CGM duopoly is stronger than ever, new players are needed to bring costs down and offer far-reaching solutions. Katy Brown and Violeta Perea Rubio were at the conference. Did we miss you? We'd love to connect! Please reach out to us to learn more about Sava and our vision for the future of preventative, personalized healthcare. Add us on LinkedIn or visit our website for more information: https://www.sava.health/ #ADA2024 #DiabetesTech #CGM #Healthtech #Sava

Thank you WellToDo for a great article! Read the full article here → https://lnkd.in/e-T-5Mb4 Read our full press release → https://lnkd.in/de4hK8pQ Check out our new website! → https://www.sava.health/

Grazie StartupItalia!! Read the full interview here → https://lnkd.in/dY85urQC Read our full press release → https://lnkd.in/de4hK8pQ Check out our new website! → https://www.sava.health/

Thank you to Balderton Capital and James Wise for a great interview with our co-founder Renato Circi for the What's Next podcast. Learn about Ren & Rafaël Michali's journey from Imperial College to entrepreneurship, the key challenges of leading a start-up, and Sava's role in transforming healthcare. 💡 Discover how Sava is building its next-gen, multi-molecule wearable biosensor to provide health insights in real-time. Sava's technology aims to revolutionize healthcare by enabling a preventative, personalized, and painless future of health monitoring. 🎧 Tune in on Spotify, Youtube or Apple Podcasts to listen to the whole episode and dive deeper into our technology! Spotify → https://lnkd.in/e5N5kqiC Apple → https://lnkd.in/ev9V4KZb YouTube → https://lnkd.in/eY-i_h2U #Sava #health #healthtech #startup #founder #biosensor #healthmonitoring